Intellia Therapeutics(NTLA) - 2019 Q4 - Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2019 Earnings Conference Call February 27, 2020 8:00 AM ET Company Participants Lina Li - Associate Director, IR John Leonard - President, CEO & Director Laura Sepp-Lorenzino - EVP & Chief Scientific Officer Glenn Goddard - EVP & CFO Conference Call Participants Maurice Raycroft - Jefferies David Allen - Barclays Mani Foroohar - SVB Leerink Madhu Kumar - Robert W. Baird & Co. Steven Seedhouse - Raymond James & Associates Max Smock - BTIG Silvan Tuerkcan - Oppenhe ...